http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110187109-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110187109-B |
| titleOfInvention | Autoantibody joint detection ELISA kit for early screening of cardia adenocarcinoma |
| abstract | The invention belongs to the technical field of tumor medicine, and particularly discloses an autoantibody joint detection ELISA kit for early screening of cardia adenocarcinoma, which comprises a solid phase carrier and a tumor-related antigen coated on the solid phase carrier, wherein the tumor-related antigen consists of Dock10, IVL, CDH1 and P53. Further, the kit further comprises a sample diluent, a second antibody diluent, positive control serum, negative control serum, a color development liquid, a stop solution and a washing solution. The ELISA kit can effectively detect the cardia adenocarcinoma, particularly the early cardia adenocarcinoma, has the detection sensitivity as high as 87.5 percent and the specificity as high as 75 percent, can be used for large-scale screening of asymptomatic people in a cardia adenocarcinoma high-incidence area, and is beneficial to screening and early discovery of the cardia adenocarcinoma of asymptomatic high-risk people. |
| priorityDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.